Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ronggao Chen"'
Autor:
Xin Hu, Guanrong Chen, Yingchen Huang, Qiyang Cheng, Jianyong Zhuo, Renyi Su, Chiyu He, Yichao Wu, Zhikun Liu, Beng Yang, Shuai Wang, Lijun Meng, Shusen Zheng, Di Lu, Qiang Wei, Jiayin Yang, Xuyong Wei, Ronggao Chen, Xiao Xu
Publikováno v:
Advanced Science, Vol 11, Iss 16, Pp n/a-n/a (2024)
Abstract Recent studies suggest that circular RNA (circRNA)‐mediated post‐translational modification of RNA‐binding proteins (RBP) plays a pivotal role in metastasis of hepatocellular carcinoma (HCC). However, the specific mechanism and potenti
Externí odkaz:
https://doaj.org/article/2704c34a0a4843d1adfe4198bed10104
Autor:
Changbiao Li, Yichao Wu, Kangchen Chen, Ronggao Chen, Shengjun Xu, Beng Yang, Zhengxing Lian, Xiaodong Wang, Kai Wang, Haiyang Xie, Shusen Zheng, Zhikun Liu, Di Wang, Xiao Xu
Publikováno v:
Cell Death and Disease, Vol 14, Iss 12, Pp 1-12 (2023)
Abstract Ferroptosis, which is driven by iron-dependent lipid peroxidation, plays an essential role in liver ischemia-reperfusion injury (IRI) during liver transplantation (LT). Gp78, an E3 ligase, has been implicated in lipid metabolism and inflamma
Externí odkaz:
https://doaj.org/article/a827021c60d24f37a261a2f30326644e
Publikováno v:
MedComm, Vol 4, Iss 6, Pp n/a-n/a (2023)
Abstract Liver transplantation (LT) stands as the gold standard for treating end‐stage liver disease and hepatocellular carcinoma, yet postoperative complications continue to impact survival rates. The liver's unique immune system, governed by a mi
Externí odkaz:
https://doaj.org/article/212b2691a8f446218834c2656f2fe54c
Autor:
Linsong Tang, Rongli Wei, Ronggao Chen, Guanghan Fan, Junbin Zhou, Zhetuo Qi, Kai Wang, Qiang Wei, Xuyong Wei, Xiao Xu
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 4402-4414 (2022)
Hepatocellular carcinoma (HCC) represents the most important type of liver cancer, the 5-year survival rate for advanced HCC is 2%. The heterogeneity of HCC makes previous models fail to achieve satisfactory results. The role of Cholesterol-based met
Externí odkaz:
https://doaj.org/article/02c866fd02fc40f3be3679d82f8f519b
Autor:
Daxian Wu, Lingjian Zhang, Shanshan Ma, Yalei Zhao, Ronggao Chen, Fen Zhang, Qiuhong Liu, Xiaowei Xu, Zhongyang Xie
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background and Aims: Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) remains a serious entity with high mortality. Growth hormone (GH) is related to the liver metabolism and regeneration. The present study aimed to explore the cha
Externí odkaz:
https://doaj.org/article/9289a2d3df954d21901d096bec07239e
Autor:
Jiong Yu, Xiaowei Shi, Jing Ma, Ronggao Chen, Siyi Dong, Sen Lu, Jian Wu, Cuilin Yan, Shusen Zheng, Lanjuan Li, Xiao Xu, Hongcui Cao
Publikováno v:
Biomolecules, Vol 11, Iss 8, p 1195 (2021)
The relationship between aseptic systemic inflammation and postoperative bacterial infection is unclear. We investigated the correlation of systemic inflammation biomarkers with 30-day clinically significant bacterial infections (CSI) after liver tra
Externí odkaz:
https://doaj.org/article/34be5f6ad0ba48dab2f39504b55766f0
Publikováno v:
Cancer Letters. 476:120-128
Hepatocellular carcinoma (HCC), the main cause of liver cancer-related death, is one of the main cancers in terms of incidence and mortality. However, HCC is difficult to target and develops strong drug resistance. Therefore, a new treatment strategy
Publikováno v:
International Journal of Biological Sciences
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and has been acknowledged as a leading cause of death among cirrhosis patients. Difficulties in early diagnosis and heterogeneity are obstacles to effective treatment, especially
Publikováno v:
International Journal of Biological Sciences; 2022, Vol. 18 Issue 2, p536-551, 16p
Autor:
Ronggao, Chen, Yiting, Qiao, Wendi, Hu, Qiyang, Cheng, Haiyang, Xie, Lin, Zhou, Xiao, Xu, Shusen, Zheng, Donghai, Jiang
Publikováno v:
American journal of cancer research. 9(10)
Side-effects and resistance substantially limit the efficacy of chemotherapy. One possible solution to this persistent problem would be co-administration of targeted therapy and chemotherapy to achieve synergistic anti-cancer effects without extra to